Brief: Oncopeptides Q2 Operating Loss Narrows To SEK 344.8 Mln

Oncopeptides AB

19/08/2021 06:10

Aug 19 (Reuters) - Oncopeptides AB  ONCO.ST :
    * ONCOPEPTIDES PUBLISHES REPORT FOR Q2 2021
    * Q2 NET SALES AMOUNTED TO SEK 66.4 M (0.0)
    * Q2 OPERATING LOSS AMOUNTED TO SEK 344.8 M (LOSS: 399.3)
    * Q2 LOSS FOR PERIOD WAS SEK 24.1 M (LOSS: 401.0)

Source text for Eikon:  ID:nWkr5rDNkQ 
Further company coverage:  ONCO.ST 

 (Gdansk Newsroom)
 ((gdansk.newsroom@thomsonreuters.com; +48 58 7696600;))